S

Swedish Orphan Biovitrum
SOBI

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
SEK111.53B
EV
SEK124.09B
Shares Outstanding
345.97M
Beta
0.19
Industry
Drug Manufacturers - Specialty & Generic

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
11
P/E 2025E
26.62x
P/Revenue 2025E
3.94x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Swedish Orphan Biovitrum AB (publ)

gainify

S

Swedish Orphan Biovitrum AB (publ)

SOBI

Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. The company operates through three segments: Haematology, Immunology...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Oelkers, Guido

Employees

1,890

IPO Date

2006-09-15

Headquarters

Norra Stationsgatan 93A, Stockholm, Stockholm County Sweden

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.